Estimating the relative risk of developing melanoma in INK4A carriers
Berwick M, Orlow I, Mahabir S, Myskowski P, Coit D, Brady M, Roy P, Song Y, Canchola R, Barz A, Halpern A, Bolognia J, Eng S, Elahi A, Begg C. Estimating the relative risk of developing melanoma in INK4A carriers. European Journal Of Cancer Prevention 2004, 13: 65-70. PMID: 15075790, DOI: 10.1097/00008469-200402000-00010.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultCase-Control StudiesChromatography, LiquidCyclin-Dependent Kinase Inhibitor p16FemaleGerm-Line MutationHumansMaleMelanomaMiddle AgedNeoplasms, Multiple PrimaryNevusNucleic Acid DenaturationOdds RatioPilot ProjectsPolymerase Chain ReactionPrevalenceRisk FactorsSkin NeoplasmsSurveys and QuestionnairesConceptsRisk factorsRelative riskMemorial Sloan-Kettering Cancer CenterStudy designSingle primaryCancer risk factorsMultiple primary melanomasRisk of melanomaNumber of neviPigmented lesion clinicNovel study designRare germline mutationsDermatology clinicCancer CenterNew study designsPrimary melanomaLesion clinicHigh prevalencePrimary casesPatientsMultiple primariesMelanomaGermline mutationsPilot studyFair skin